A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

NCT01462292 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophies

Interventions

DRUG: GSK2402968 3mg/kg/week
DRUG: GSK2402968 6 mg/kg/week
DRUG: Placebo to match GSK2402968 3 mg/kg/week
DRUG: Placebo to match GSK2402968 6 mg/kg/week

Sponsor

GlaxoSmithKline